Consistent with this notion and high RNF12 expression patterns seen in invasive breast cancer, we observed that RNF12 is needed for efficient induction of TGF-β of mesenchymal markers and TGF-β target genes in the malignant phenotypes of MDA-MB 231 cells. The gene discussed is RLIM; the disease is invasive breast carcinoma.